SELLAS Life Sciences (SLS) EBITDA (2011 - 2017)
SELLAS Life Sciences (SLS) reported EBITDA of -$4.41 million for Q3 2017, compared with -$6.44 million a year earlier.
Powered by 
Analysis
SELLAS Life Sciences (SLS) EBITDA (2011 - 2017) Analysis & Trends
Over the twelve months ended Sep 30, 2017, SELLAS Life Sciences' EBITDA came in at -$5.71 million; for FY2016, it was -$15.99 million.
- By year, EBITDA came in at -$34.11 million in FY2015, -$43.81 million in FY2014, -$28.2 million in FY2013 and -$21.15 million in FY2012.
- Five-year quarterly EBITDA spans a low of -$15.55 million in Q2 2014 and a high of $8.65 million in Q4 2016.
- Per Business Quant data, the three quarters before Q3 2017 came in at -$4.89 million (Q2 2017), -$5.06 million (Q1 2017) and $8.65 million (Q4 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | SELLAS Life Sciences | 2.34 Bn | 2.34 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.89 Mn |
| Mar 31, 2017 | -5.06 Mn |
| Dec 31, 2016 | 8.65 Mn |
| Sep 30, 2016 | -6.44 Mn |
| Jun 30, 2016 | -9.23 Mn |
| Mar 31, 2016 | -8.96 Mn |
| Dec 31, 2015 | -7.79 Mn |
| Sep 30, 2015 | -8.51 Mn |
| Jun 30, 2015 | -9.00 Mn |
| Mar 31, 2015 | -8.81 Mn |
| Dec 31, 2014 | -9.95 Mn |
| Sep 30, 2014 | -10.69 Mn |
| Jun 30, 2014 | -15.55 Mn |
| Mar 31, 2014 | -11.62 Mn |
| Dec 31, 2013 | -6.88 Mn |
| Sep 30, 2013 | -6.77 Mn |
| Jun 30, 2013 | -7.95 Mn |
| Mar 31, 2013 | -6.61 Mn |
| Dec 31, 2012 | -5.58 Mn |
API Access
SELLAS Life Sciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();